Results

Medicamen Biotech Ltd. - Financial Results For The Quarter/Year Ended 31.03.2019.

| Updated on May 30, 2019 Published on May 30, 2019

We wish to inform you that the Board of Directors of the Company at its meeting held today has inter alia:-

1. Approved the Audited Financial Statements of the Company for the financial year ended March 31, 2019 and the Audited Financial results for the quarter/year ended March 31, 2019.

2. Recommended a Dividend of Rs. 1 per equity share of Rs. 10/-each for the financial year ended March 31, 2019.

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following:

a) Statement showing the Audited Financial Results of the Company for the quarter/financial year ended March 31, 2019 as Annexure-A and

b) Auditors Report on the Audited Financial Results as Annexure-B.

The meeting of the Board of Directors commenced on 11.30 a.m. and concluded at 01.20 p.m.

Pdf Link: Medicamen Biotech Ltd. - Financial Results For The Quarter/Year Ended 31.03.2019.

Source : BSE - www.bseindia.com

Published on May 30, 2019
This article is closed for comments.
Please Email the Editor